MARUX CONTINUOUS BIOMANUFACTURING
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

MARUX CONTINUOUS BIOMANUFACTURING Trademark

Serial Number: 79441470

MARUX CONTINUOUS BIOMANUFACTURING is a trademark filed by Fujifilm Diosynth Biotechnologies UK Limited on November 3, 2025. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Fujifilm Diosynth Biotechnologies UK Limited

Belasis Avenue

Entity Type: 24

Trademark Details

Filing Date

November 3, 2025

Registration Date

Not Registered

Published for Opposition

September 1, 2026

Goods & Services

Scientific, industrial and technical research, product development and scientific analysis services related to continuous production, manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells; process development, namely, development of scientific research processes related to the continuous production, manufacture and purification, of biological products such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells; Scientific, industrial and technical research, product development and scientific analysis services related to continuous production, manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells; process development, namely, development of scientific research processes related to the continuous production, manufacture and purification, of biological products such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells; industrial design services related to the continuous production, manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells; provision of laboratory research facilities for scientific, industrial and technical research development related to the continuous production, manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells.

Continuous production, manufacture and purification, of biological products, namely, cells, viruses and biomolecules, genes and proteins, obtained from recombinant cells, to the order and specification of others; Continuous purification, expression, namely, production of proteins by recombinant cells, and isolation, namely, separation and extraction , of biological products, namely, cells, viruses and biomolecules, genes and proteins, obtained from recombinant cells, to the order and specification of others; Continuous connected upstream and downstream production of biological products, namely, cells, viruses and biomolecules, genes and proteins, obtained from recombinant cells, to the order and specification of others.

Filing History

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 5, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 5, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Aug 5, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Aug 5, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 5, 2026 CNEA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 5, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Aug 5, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Aug 5, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 5, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2026 TROA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 2, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 2, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 2, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 2, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 2, 2026 COAR
REFUSAL PROCESSED BY IB
May 21, 2026 RFNT
NEW REPRESENTATIVE AT IB RECEIVED
May 7, 2026 NREP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 1, 2026 RFCS
REFUSAL PROCESSED BY MPU
Apr 30, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 21, 2026 RFCR
NON-FINAL ACTION WRITTEN
Mar 20, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 16, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 18, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 18, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 15, 2026 REPR